Medy-Tox Inc. (KOSDAQ: A086900)
Health Care · Biotechnology · KR
₩66,600.00
-1.19% today · -43.8% 1Y
Medy-Tox Inc. (KOSDAQ: A086900) operates in the Biotechnology industry within the Health Care sector. The company is valued at $319.37M.
Over the last twelve months the share price has lost 43.8%, trading between 65.60K and 141.10K.
Tweenvest scores Medy-Tox Inc. across four factors: quality 83/100, value 73/100, dividend 22/100. Its strongest factor is quality.
A086900 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $319.37M
- Revenue (TTM)
- $162.13M
- P/E
- 29.76
- EPS
- 2,237.82
- Dividend yield
- 1.80%
- Beta (5Y)
- 0.39
- 52-week high
- ₩141,100.00
- 52-week low
- ₩65,600.00
- Avg volume (3M)
- —
- Shares outstanding
- 6.46M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hansa Biopharma AB (publ)OM: HNSA | $336.45M | Skr33.38 | +0.60% |
| Cabaletta Bio, Inc.NasdaqGS: CABA | $334.00M | $1.95 | -1.02% |
| GC Corp.KOSE: A005250 | $326.61M | ₩9,680.00 | +2.54% |
| Cypherpunk Technologies Inc.NasdaqCM: CYPH | $326.53M | $2.81 | -7.26% |
| Indaptus Therapeutics, Inc.NasdaqCM: INDP | $317.12M | $2.37 | -0.42% |
| TCM Biotech International Corp.TWSE: 4169 | $315.94M | NT$151.50 | +2.02% |
| Benitec Biopharma Inc.NasdaqCM: BNTC | $313.25M | $8.75 | -2.56% |
| BridgeBio Oncology Therapeutics, Inc.NasdaqGM: BBOT | $311.88M | $3.42 | -12.08% |
Figures last refreshed Oct 4, 2026.